isosorbide dinitrate has been researched along with rofecoxib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; Cena, C; Chegaev, K; Fruttero, R; Gasco, A; Lazzarato, L; Marini, E; Rolando, B; Tosco, P | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
2 other study(ies) available for isosorbide dinitrate and rofecoxib
| Article | Year |
|---|---|
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties.
Topics: Animals; Aorta; Cyclooxygenase 2 Inhibitors; Humans; Imidazoles; In Vitro Techniques; Models, Molecular; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide Donors; Rats; Structure-Activity Relationship; Sulfonamides; Vasodilator Agents | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |